These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 1372009)
21. High and low affinity binding of heparin-binding growth factor to a 130-kDa receptor correlates with stimulation and inhibition of growth of a differentiated human hepatoma cell. Kan M; DiSorbo D; Hou JZ; Hoshi H; Mansson PE; McKeehan WL J Biol Chem; 1988 Aug; 263(23):11306-13. PubMed ID: 2457020 [TBL] [Abstract][Full Text] [Related]
22. Ability of different chemically modified heparins to potentiate the biological activity of heparin-binding growth factor 1: lack of correlation with growth factor binding. Belford DA; Hendry IA; Parish CR Biochemistry; 1992 Jul; 31(28):6498-503. PubMed ID: 1378755 [TBL] [Abstract][Full Text] [Related]
23. Potentiation of the activity of mouse liver-derived HBGF-1-like growth factor by heparin and dithiothreitol: evidence for the involvement of a plasma factor. Nagasaki T; Lieberman MA Biochim Biophys Acta; 1991 Sep; 1094(3):330-8. PubMed ID: 1716989 [TBL] [Abstract][Full Text] [Related]
24. Heparin-binding growth factor-1 modulation of plasminogen activator inhibitor-1 expression. Interaction with cAMP and protein kinase C-mediated pathways. Konkle BA; Kollros PR; Kelly MD J Biol Chem; 1990 Dec; 265(35):21867-73. PubMed ID: 1701436 [TBL] [Abstract][Full Text] [Related]
25. Bifunctional effects of transforming growth factor-beta (TGF-beta) on endothelial cell growth correlate with phenotypes of TGF-beta binding sites. Myoken Y; Kan M; Sato GH; McKeehan WL; Sato JD Exp Cell Res; 1990 Dec; 191(2):299-304. PubMed ID: 1701723 [TBL] [Abstract][Full Text] [Related]
26. Immunolocalization of heparin-binding growth factors (HBGF) types 1 and 2 in rat liver. Selective hyperexpression of HBGF-2 in carbon tetrachloride-induced fibrosis. Charlotte F; Win KM; Preaux AM; Mavier P; Dhumeaux D; Zafrani ES; Rosenbaum J J Pathol; 1993 Apr; 169(4):471-6. PubMed ID: 7684779 [TBL] [Abstract][Full Text] [Related]
27. Heparin-binding growth factor-I (endothelial cell growth factor) binds to endothelium in vivo. Rosengart TK; Kupferschmid JP; Ferrans VJ; Casscells W; Maciag T; Clark RE J Vasc Surg; 1988 Feb; 7(2):311-7. PubMed ID: 2448501 [TBL] [Abstract][Full Text] [Related]
28. A novel sequence in the coiled-coil domain of Stat3 essential for its nuclear translocation. Ma J; Zhang T; Novotny-Diermayr V; Tan AL; Cao X J Biol Chem; 2003 Aug; 278(31):29252-60. PubMed ID: 12746441 [TBL] [Abstract][Full Text] [Related]
29. Isolation and characterization of a macrophage-derived heparin-binding growth factor. Besner G; Higashiyama S; Klagsbrun M Cell Regul; 1990 Oct; 1(11):811-9. PubMed ID: 2088527 [TBL] [Abstract][Full Text] [Related]
30. Heparin-binding growth factor gene expression and receptor characteristics in normal rat prostate and two transplantable rat prostate tumors. Mansson PE; Adams P; Kan M; McKeehan WL Cancer Res; 1989 May; 49(9):2485-94. PubMed ID: 2468410 [TBL] [Abstract][Full Text] [Related]
31. Heparin protects heparin-binding growth factor-I from proteolytic inactivation in vitro. Rosengart TK; Johnson WV; Friesel R; Clark R; Maciag T Biochem Biophys Res Commun; 1988 Apr; 152(1):432-40. PubMed ID: 2451918 [TBL] [Abstract][Full Text] [Related]
32. Nuclear translocation and DNA recognition signals colocalized within the bZIP domain of cyclic adenosine 3',5'-monophosphate response element-binding protein CREB. Waeber G; Habener JF Mol Endocrinol; 1991 Oct; 5(10):1431-8. PubMed ID: 1837841 [TBL] [Abstract][Full Text] [Related]
33. Isolation and characterization of different molecular and chromatographic forms of heparin-binding growth factor 1 from bovine brain. McKeehan WL; Crabb JW Anal Biochem; 1987 Aug; 164(2):563-9. PubMed ID: 2445228 [TBL] [Abstract][Full Text] [Related]
34. Subcellular localization and biological activity of M(r) 18,000 basic fibroblast growth factor: site-directed mutagenesis of a putative nuclear translocation sequence. Presta M; Gualandris A; Urbinati C; Rusnati M; Coltrini D; Isacchi A; Caccia P; Bergonzoni L Growth Factors; 1993; 9(4):269-78. PubMed ID: 8148156 [TBL] [Abstract][Full Text] [Related]
35. Fibronectin, not laminin, mediates heparin-dependent heparin-binding growth factor type I binding to substrata and stimulation of endothelial cell growth. Kan M; Shi EG In Vitro Cell Dev Biol; 1990 Dec; 26(12):1151-6. PubMed ID: 1706698 [TBL] [Abstract][Full Text] [Related]
36. The half-lives of platelet-derived growth factor A- and B-chain mRNAs are similar in endothelial cells and unaffected by heparin-binding growth factor-1 or cycloheximide. Gay CG; Winkles JA J Cell Physiol; 1991 Apr; 147(1):121-7. PubMed ID: 1709940 [TBL] [Abstract][Full Text] [Related]
37. Characterization and molecular cloning of a putative binding protein for heparin-binding growth factors. Wu DQ; Kan MK; Sato GH; Okamoto T; Sato JD J Biol Chem; 1991 Sep; 266(25):16778-85. PubMed ID: 1885605 [TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics and distribution of heparin-binding growth factor I (endothelial cell growth factor) in the rat. Rosengart TK; Kuperschmid JP; Maciag T; Clark RE Circ Res; 1989 Feb; 64(2):227-34. PubMed ID: 2463884 [TBL] [Abstract][Full Text] [Related]
40. Differential inhibitory effects of TGF-beta on EGF-, PDGF-, and HBGF-1-stimulated MG63 human osteosarcoma cell growth: possible involvement of growth factor interactions at the receptor and postreceptor levels. Mioh H; Chen JK J Cell Physiol; 1989 Jun; 139(3):509-16. PubMed ID: 2472412 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]